AVBP

ArriVent BioPharma

Fundamental data last updated:April 13, 2026

company profile

SECTOR

Healthcare

industry

Biotechnology

Exchange

Nasdaq

County of HQ

United States

Next Earnings Date

05/11/26

Business Summary

Krispy Kreme generates cash by producing and distributing branded doughnuts and related products through retail shops, grocery placements, and partnerships. The model relies on high product turnover, brand recognition, and recurring consumer demand for low-ticket indulgences. Its moat is rooted in brand equity and distribution relationships rather than proprietary technology, allowing it to place product directly into high-traffic consumer channels. Cash generation depends heavily on operational efficiency, throughput, and maintaining strong retail partnerships to keep volumes high and fixed costs absorbed.

VALUATION

P/E

-

Market Cap ($M USD)

$1,125

Forward P/E

-

PEG

-

PRICE TO SALES

-

PRICE TO BOOK

3.7

EV / EBITDA

-4.6

5-Year Average P/E

DIVIDEND

Yield

-

Annual Payout

-

Payout Ratio

-

Consecutive Years of Dividend Growth

0

5-Year Dividend Growth Rate

-

Financial Health & Profitability

Earnings Per Share

-$4.32

Next Year EPS Growth Estimate

-$3.27

Next Year Revenue Growth Estimate

-

Return on Equity (ROE)

-54.10%

Operating Margin

-

Debt-to-Equity

0

Piotroski F-Score

2

Altman Z-Score

23.7

Return on Invested Capital (ROIC)

-62.80%%

Current Ratio

12.8

Quick Ratio

Gainseekers Quantitative Analysis

Summary

At a $571M market cap, DNUT screens optically “cheap” on Price/Sales of 0.4 and Price/Book of 0.9, but this is not a classic deep value mispricing—it’s distress pricing. There is no P/E or Forward P/E because earnings are deeply negative, with EPS at -5.7 and EPS Next Year (Est.) at -$3.04, signaling continued losses rather than recovery. An Altman Z-Score of 0.2 is flashing severe financial distress risk, and with Operating Margin at -80.00% and ROIC at -20.00%, the business is destroying capital at scale. This is not a growth story, not a GARP setup, and not a statistically cheap franchise—it is a balance sheet and profitability turnaround speculation with asymmetric downside if execution falters.

AI Exposure / Tech Reliance

As a Consumer Defensive company in Grocery Stores, DNUT operates in a low-tech, operationally intensive environment where AI leverage is incremental rather than transformative. Margins at -80.00% suggest operational inefficiency, and modern tech integration would need to materially improve cost structure to matter. The industry is resilient in demand, but technology alone will not fix negative ROIC of -20.00%.

The Bull Case

The only rational bull thesis starts with valuation compression already pricing in disaster: Price/Sales at 0.4 and Price/Book at 0.9 imply limited expectations for recovery. A Piotroski F-Score of 6 suggests the fundamentals are not collapsing across all dimensions and that there are pockets of operational stability despite the headline losses. Return on Equity at 3.30%, while modest, is positive, indicating that equity capital is not entirely unproductive. With a TTM Yield of 2.2 and Dividend Per Share USD listed at 1.10% alongside a Payout Ratio of $0.14, income support may attract yield-focused deep value investors if stability holds. At this valuation, even a partial normalization of margins from -80.00% could create sharp multiple expansion from depressed levels.

The Bear Case

The bear case is overwhelming. Operating Margin of -80.00% combined with ROIC of -20.00% shows a structurally broken cost base, not a cyclical dip. Debt / Equity at -2.20% paired with a Current Ratio of 0.4 signals serious balance sheet fragility and weak liquidity, while the Altman Z-Score of 0.2 points to elevated bankruptcy risk. EPS of -5.7 with next year still negative at -$3.04 and Sales Growth Next Year at -$0.08 indicates no visible earnings inflection. With no P/E, no Forward P/E, and PEG Forward unavailable, there is no valuation anchor based on profitability—this is a turnaround gamble sitting in a defensive sector that should not be producing these kinds of numbers.

Market Sentiment & Smart Money

Short Interest %

21.30%

Analyst Consensus

1.14

Average Analyst Price Target

$42.92

Institutional Ownership %

96.50%

1-Year Beta

1.09

Insider Buying % (6 Mo)

2.90%%

Distance to 52-Week High

91.80%%

Distance to 52-Week Low

158.10%%